190 related articles for article (PubMed ID: 8751436)
1. Transcriptional activation by BRCA1.
Chapman MS; Verma IM
Nature; 1996 Aug; 382(6593):678-9. PubMed ID: 8751436
[No Abstract] [Full Text] [Related]
2. Box BRCA1 tumour inhibition.
Goodman L
Nat Genet; 1996 Mar; 12(3):224. PubMed ID: 8589706
[No Abstract] [Full Text] [Related]
3. Induction of apoptosis by the tumor suppressor protein BRCA1.
Shao N; Chai YL; Shyam E; Reddy P; Rao VN
Oncogene; 1996 Jul; 13(1):1-7. PubMed ID: 8700535
[TBL] [Abstract][Full Text] [Related]
4. [BRCA1 and cancer: a new lead].
Larsen CJ
Bull Cancer; 2000 Oct; 87(10):693-4. PubMed ID: 11185523
[No Abstract] [Full Text] [Related]
5. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
[No Abstract] [Full Text] [Related]
6. Breaking down BRCA1.
Nat Genet; 1994 Dec; 8(4):310. PubMed ID: 7894474
[No Abstract] [Full Text] [Related]
7. Progress made toward a diagnostic test for breast and ovarian cancer risk.
Int J Fertil Menopausal Stud; 1995; 40(3):117. PubMed ID: 7663536
[No Abstract] [Full Text] [Related]
8. A human BRCA1 gene knockout.
Boyd M; Harris F; McFarlane R; Davidson HR; Black DM
Nature; 1995 Jun; 375(6532):541-2. PubMed ID: 7791869
[No Abstract] [Full Text] [Related]
9. Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.
Sobol H; Stoppa-Lyonnet D; Bressac-de-Paillerets B; Peyrat JP; Kerangueven F; Janin N; Noguchi T; Eisinger F; Guinebretiere JM; Jacquemier J; Birnbaum D
Cancer Res; 1996 Jul; 56(14):3216-9. PubMed ID: 8764110
[TBL] [Abstract][Full Text] [Related]
10. A common BRCA1 mutation in the Ashkenazim.
Goldgar DE; Reilly PR
Nat Genet; 1995 Oct; 11(2):113-4. PubMed ID: 7550331
[No Abstract] [Full Text] [Related]
11. Transcriptional activation functions in BRCA2.
Milner J; Ponder B; Hughes-Davies L; Seltmann M; Kouzarides T
Nature; 1997 Apr; 386(6627):772-3. PubMed ID: 9126734
[No Abstract] [Full Text] [Related]
12. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.
Nordling M; Karlsson P; Wahlström J; Engwall Y; Wallgren A; Martinsson T
Cancer Res; 1998 Apr; 58(7):1372-5. PubMed ID: 9537232
[TBL] [Abstract][Full Text] [Related]
13. Are BRCA1- and BRCA2-associated breast cancers different?
Offit K
J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336
[No Abstract] [Full Text] [Related]
14. The Brca1 and Brca2 proteins and tumor pathogenesis.
Ingvarsson S
Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to breast and ovarian cancer.
Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.
Le Page F; Randrianarison V; Marot D; Cabannes J; Perricaudet M; Feunteun J; Sarasin A
Cancer Res; 2000 Oct; 60(19):5548-52. PubMed ID: 11034101
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
[TBL] [Abstract][Full Text] [Related]
18. [Roles of BRCA1 and BRCA2 in DNA repair and tumor suppression].
Yano K; Miki Y
Tanpakushitsu Kakusan Koso; 2001 Jun; 46(8 Suppl):1055-62. PubMed ID: 11436293
[No Abstract] [Full Text] [Related]
19. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
[TBL] [Abstract][Full Text] [Related]
20. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
